GSMS, Inc. recalls GSMS Incorporated — Ranitidine HCl 150mg and 300mg Capsules
- Recall date
- November 15, 2019
- Source
- U.S. Food & Drug Administration (FDA) — recall announcement
- Brand / firm
- GSMS, Inc., GSMS Incorporated
Why it was recalled
Potential presence of N-Nitrosodimethylamine (NDMA) above levels established by the FDA — Ingredient Level
What was recalled
Ranitidine HCl 150mg and 300mg Capsules
Read the official recall notice →
Get recall alerts
Free email alert whenever GSMS, Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: GSMS, Inc., GSMS Incorporated